• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer

    3/6/25 7:30:00 AM ET
    $ZBH
    Industrial Specialties
    Health Care
    Get the next $ZBH alert in real time by email

    WARSAW, Ind., March 6, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Kristen Cardillo as Senior Vice President, Chief Communications Officer. Reporting to President and CEO Ivan Tornos, Ms. Cardillo will join the Company on March 10, 2025, to lead Zimmer Biomet's global communications strategy, enhancing engagement with key stakeholders and amplifying the Company's position as a leader in MedTech.

    Kristen Cardillo

    "Kristen's expertise in shaping compelling corporate narratives and leading high-impact communications strategies will be invaluable as we continue driving Zimmer Biomet's bold vision forward," said Ivan Tornos, President and CEO, Zimmer Biomet. "Her leadership will help amplify our innovation story, strengthen engagement with key internal and external stakeholders, and further elevate our brand in the MedTech industry. I'm excited to welcome Kristen to the team and look forward to the contributions she will make."

    Ms. Cardillo joins Zimmer Biomet from life science tools company 10x Genomics, where she was Vice President of Corporate Communications. Previously she served as Vice President of Global Communications and Public Relations for Becton, Dickinson and Company (BD). In this role, Ms. Cardillo played an integral part in advancing BD's strategy, brand and culture through internal communications, public and media relations, social media and financial communications. Prior to BD, she held positions of increasing responsibility in internal and external communications with CareFusion and Cardinal Health.

    Ms. Cardillo holds a Bachelor of Science degree in Telecommunications from Ohio University.

    About Zimmer Biomet

    Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

    With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.

    For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet.

    Media

    Heather Zoumas-Lubeski

    445-248-0577

    [email protected]

    Investors

    David DeMartino

    646-531-6115

    [email protected]

    Zach Weiner

    908-591-6955

    [email protected]

    (PRNewsfoto/Zimmer Biomet Holdings, Inc.)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-names-kristen-cardillo-as-senior-vice-president-chief-communications-officer-302393822.html

    SOURCE Zimmer Biomet Holdings, Inc.

    Get the next $ZBH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ZBH

    DatePrice TargetRatingAnalyst
    12/17/2024$125.00 → $128.00Neutral → Overweight
    Analyst
    9/10/2024Peer Perform
    Wolfe Research
    7/1/2024$140.00 → $115.00Overweight → Neutral
    Piper Sandler
    5/30/2024$129.00Neutral
    Goldman
    5/21/2024$150.00Hold → Buy
    Argus
    1/4/2024$135.00 → $125.00Outperform → In-line
    Evercore ISI
    10/20/2023$120.00Neutral
    ROTH MKM
    8/28/2023$139.00Neutral → Buy
    BTIG Research
    More analyst ratings

    $ZBH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Jafry Syed A. bought $223,641 worth of shares (2,135 units at $104.75), increasing direct ownership by 111% to 4,060 units (SEC Form 4)

      4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)

      11/13/23 4:02:02 PM ET
      $ZBH
      Industrial Specialties
      Health Care
    • Begley Christopher B bought $117,114 worth of shares (1,000 units at $117.11), increasing direct ownership by 39% to 3,540 units (SEC Form 4)

      4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)

      9/29/23 4:05:41 PM ET
      $ZBH
      Industrial Specialties
      Health Care